Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms.

Source:http://linkedlifedata.com/resource/pubmed/id/21841134

J. Immunol. 2011 Sep 15 187 6 3003-14

Download in:

View as

General Info

PMID
21841134